MedPath

Tizanidine

Tizanidine Tablets USP

Approved
Approval ID

9c70817f-e721-4f04-b095-0747702df614

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Apr 28, 2010

Manufacturers
FDA

Altura Pharmaceuticals, Inc.

DUNS: 006890545

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Tizanidine

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code63874-087
Application NumberANDA076286
Product Classification
M
Marketing Category
C73584
G
Generic Name
Tizanidine
Product Specifications
Route of AdministrationORAL
Effective DateApril 28, 2010
FDA Product Classification

INGREDIENTS (5)

ANHYDROUS LACTOSEInactive
Code: 3SY5LH9PMK
Classification: IACT
TIZANIDINE HYDROCHLORIDEActive
Quantity: 2 mg in 1 1
Code: B53E3NMY5C
Classification: ACTIB
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61U
Classification: IACT
STEARIC ACIDInactive
Code: 4ELV7Z65AP
Classification: IACT
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Tizanidine - FDA Drug Approval Details